Rodeo Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 3
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $721M
Latest Deal Amount

Rodeo Therapeutics General Information

Description

Developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types. The company's therapies increase tissue levels of prostaglandin PGE2 through inhibition of a prostaglandin-degrading enzyme (15-PGDH) and accelerate hematopoietic stem cell reconstitution following bone marrow transplant, protect against colitis and promote liver regeneration in a variety of animal models, enabling physicians to efficiently treat inflammatory bowel diseases and promote blood cell reconstitution following bone marrow transplant.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Primary Office
  • 2815 Eastlake Avenue East
  • Suite 300
  • Seattle, WA 98102
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rodeo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 30-Mar-2021 $721M 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series A1) 02-Apr-2020 00.000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 25-Jul-2017 $5.9M $5.9M 000.00 Completed Startup
To view Rodeo Therapeutics’s complete valuation and funding history, request access »

Rodeo Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00 000
To view Rodeo Therapeutics’s complete cap table history, request access »

Rodeo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types. The company'
Drug Discovery
Seattle, WA
3 As of 2021
000.00
0000 0000-00-00
000000&0 000.00

0000 000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000 0

rit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
0000000000000
South San Francisco, CA
0 As of 0000
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rodeo Therapeutics Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed South San Francisco, CA 0 00000 000000000000 00000
000000000000 00000 Venture Capital-Backed Jerusalem, Israel 00 000.00 000000000000 000.00
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
000000 0000 Formerly VC-backed Jerusalem, Israel 000 00000 00000000 00000
You’re viewing 5 of 41 competitors. Get the full list »

Rodeo Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rodeo Therapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Accelerator Life Science Partners Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Eli Lilly and Company Foundation Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »